NXP Semiconductors N.V. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? NXP Semiconductors N.V. Common Stock trades at $225.17 (market cap $58.27B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.69 (market cap $58.74B). The key difference: NXP Semiconductors N.V. Common Stock and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) are close in size by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| NXPI | TAK | |
|---|---|---|
Market Cap | $58.27B | $58.74B |
Volume | 3,950,702 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $332.67 | $19.05 |
52-Week Low | $184.19 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $66.38B | $86.65B |
Dividend Yield | 1.76% | 3.33% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →